rs869320683
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_001010892.3(RSPH4A):c.921+3_921+6del variant causes a splice donor, splice donor region, coding sequence, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000461 in 1,562,432 control chromosomes in the GnomAD database, including 3 homozygotes. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.00028 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000021 ( 2 hom. )
Consequence
RSPH4A
NM_001010892.3 splice_donor, splice_donor_region, coding_sequence, intron
NM_001010892.3 splice_donor, splice_donor_region, coding_sequence, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.37
Genes affected
RSPH4A (HGNC:21558): (radial spoke head component 4A) This gene encodes a protein that appears to be a component the radial spoke head, as determined by homology to similar proteins in the biflagellate alga Chlamydomonas reinhardtii and other ciliates. Radial spokes, which are regularly spaced along cilia, sperm, and flagella axonemes, consist of a thin 'stalk' and a bulbous 'head' that form a signal transduction scaffold between the central pair of microtubules and dynein. Mutations in this gene cause primary ciliary dyskinesia 1, a disease arising from dysmotility of motile cilia and sperm. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PP5
Variant 6-116623001-TAGTA-T is Pathogenic according to our data. Variant chr6-116623001-TAGTA-T is described in ClinVar as [Pathogenic]. Clinvar id is 88863.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-116623001-TAGTA-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSPH4A | NM_001010892.3 | c.921+3_921+6del | splice_donor_variant, splice_donor_region_variant, coding_sequence_variant, intron_variant | 2/6 | ENST00000229554.10 | NP_001010892.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSPH4A | ENST00000229554.10 | c.921+3_921+6del | splice_donor_variant, splice_donor_region_variant, coding_sequence_variant, intron_variant | 2/6 | 1 | NM_001010892.3 | ENSP00000229554 | P1 | ||
RSPH4A | ENST00000368581.8 | c.921+3_921+6del | splice_donor_variant, splice_donor_region_variant, coding_sequence_variant, intron_variant | 2/5 | 1 | ENSP00000357570 | ||||
RSPH4A | ENST00000368580.4 | c.921+3_921+6del | splice_donor_variant, splice_donor_region_variant, coding_sequence_variant, intron_variant | 2/5 | 5 | ENSP00000357569 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152222Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
42
AN:
152222
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000320 AC: 8AN: 249652Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135372
GnomAD3 exomes
AF:
AC:
8
AN:
249652
Hom.:
AF XY:
AC XY:
5
AN XY:
135372
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000213 AC: 30AN: 1410092Hom.: 2 AF XY: 0.0000156 AC XY: 11AN XY: 704904
GnomAD4 exome
AF:
AC:
30
AN:
1410092
Hom.:
AF XY:
AC XY:
11
AN XY:
704904
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000276 AC: 42AN: 152340Hom.: 1 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74486
GnomAD4 genome
AF:
AC:
42
AN:
152340
Hom.:
Cov.:
33
AF XY:
AC XY:
23
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 11 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2013 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | Jan 04, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 12, 2022 | - - |
Primary ciliary dyskinesia Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2024 | The c.921+3_921+6delAAGT intronic pathogenic mutation, located in intron 2 of the RSPH4A gene, results from a deletion of 4 nucleotides within intron 2 of the RSPH4A gene. This mutation was first identified in the homozygous state in 8 individuals from 6 unrelated families with primary ciliary dyskinesia, without situs abnormalities; in vitro functional studies found this intronic mutation results in an out of frame deletion of exon 2 and a premature stop codon (p.Y230Qfs*8) (Daniels ML et al. Hum. Mutat., 2013 Oct;34:1352-6). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Pathogenic, criteria provided, single submitter | clinical testing | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Apr 26, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change falls in intron 2 of the RSPH4A gene. It does not directly change the encoded amino acid sequence of the RSPH4A protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is present in population databases (rs547686445, gnomAD 0.02%). This variant has been observed in individual(s) with primary ciliary dyskinesia (PMID: 23798057). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 88863). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in exon 2 skipping and introduces a premature termination codon (PMID: 23798057). The resulting mRNA is expected to undergo nonsense-mediated decay. For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 22, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 30, 2020 | Intronic +5 splice site variant in a gene for which loss-of-function is a known mechanism of disease, and splice predictors support a deleterious effect; This variant is associated with the following publications: (PMID: 31589614, 23798057) - |
RSPH4A-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 24, 2024 | The RSPH4A c.921+3_921+6delAAGT variant is predicted to result in an intronic deletion. This variant has been reported in the homozygous and compound heterozygous state in 9 individuals with primary ciliary dyskinesia from 7 unrelated families with Puerto Rican ancestry (Daniels et al. 2013. PubMed ID: 23798057). Function analysis of this variant showed an out-of-frame deletion of exon 2 leading to a premature protein termination (p.Tyr230Glnfs*8) (Daniels et al. 2013. PubMed ID: 23798057). In summary, this variant is interpreted as pathogenic. - |
Kartagener syndrome Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | GeneReviews | Sep 03, 2015 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at